(b) A pharmacist consultant shall:

1. (1) Register as a dispensary agent under the Arkansas Medical Marijuana Amendment of 2016, Ark. Const. amend. 98, and follow all procedures;

2. (2) Develop and provide training to other dispensary agents at least one (1) time every twelve (12) months from the initial date of the opening of the dispensary on the following subjects:

   1. (A) Guidelines for providing information to qualifying patients related to risks, benefits, and side effects associated with medical marijuana;
   2. (B) Guidelines for recognizing signs and symptoms of substance abuse; and
   3. (C) Guidelines for refusing to provide medical marijuana to an individual who appears to be impaired or abusing medical marijuana;
3. (3) Assist in the development and implementation of review and improvement processes for patient education and support provided by the dispensary;

4. (4) Provide oversight for the development and dissemination of:

   1. (A) Education materials for qualifying patients and designated caregivers that include:

(i) Information about possible side effects and contraindications of medical marijuana;

1. (ii) Guidelines for notifying the physician who provided the written certification for medical marijuana if side effects or contraindications occur;

   1. (iii) A description of the potential effects of differing strengths of medical marijuana strains and products;

      1. (iv) Information about potential drug-to-drug interactions, including interactions with:

(b) (b) Prescription drugs;

1. (c) (c) Nonprescription drugs; and

   1. (d) (d) Supplements;

      1. (v) Techniques for the use of medical marijuana and marijuana paraphernalia; and
      2. (vi) Information about different methods, forms, and routes of medical marijuana administration;

   2. (B) Systems for documentation by a qualifying patient designated caregiver of the symptoms of a qualifying patient that includes:

      1. (i) A logbook;
      2. (ii) A rating scale for pain and symptoms; and
      3. (iii) Guidelines for a patient’s self-assessment; and
   3. (C) Policies and procedures for refusing to provide medical marijuana to an individual who appears to be impaired or abusing medical marijuana; and

2. (5) Be accessible by the dispensary or dispensary agent through:

   1. (A) Telephonic means at all times during operating hours; and

   2. (B) Telephone or video conference for a patient consultant during operating hours.

      1. (c) A dispensary shall:
3. (1) Post signage at the check-in station of the dispensary notifying the qualifying patient, visiting patient, or caregiver of the availability of a pharmacist consultant;
4. (2) Provide to new qualifying patients, visiting patients, or caregivers a card containing language about a consultation with a pharmacist consultant and the contact information of the pharmacist consultant; and

5. (3) Post information on the website of the dispensary regarding:

   1. (A) A consultation with a pharmacist consultant;
   2. (B) The availability of the pharmacist consultant; and
   3. (C) The contact information of the pharmacist consultant.